San Diego based-Sorrento Therapeutics announced it had found an antibody that was capable of neutralizing SARS-CoV-2 virus infection.

The company said it was 100% effective.

However, there have been no animal or human trials, and experts warned against overreaction

The antibody if effective could eventually become part of Sorrento’s COVI-SHIELD, a planned cocktail using antibodies.

The new sent the stock climbing but it closed Monday at $6.50 after opening at $9.98.